Article in Antioxidants (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 3 institutions in 1 country.
Neelam AhujaBone-Muscle Research Center, College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, TX 76010, USA.
Kamal AwadBone-Muscle Research Center, College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, TX 76010, USA.ORCID 0000-0003-3621-1136
Su YangDepartment of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX 76010, USA.
He DongDepartment of Chemistry and Biochemistry, University of Texas at Arlington, Arlington, TX 76010, USA.ORCID 0000-0002-8494-0475
Antonios MikosCenter for Engineering Complex Tissues, Center for Excellence in Tissue Engineering, Rice University, Houston, TX 77005, USA.
Pranesh AswathDepartment of Material Science and Engineering, University of Texas at Arlington, Arlington, TX 76010, USA.ORCID 0000-0003-2885-1918
Simon YoungDepartment of Oral and Maxillofacial Surgery, University of Texas Health Science Center at Houston, Houston, TX 77054, USA.ORCID 0000-0002-8198-7083
Marco BrottoBone-Muscle Research Center, College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, TX 76010, USA.
Venu VaranasiBone-Muscle Research Center, College of Nursing and Health Innovation, University of Texas at Arlington, Arlington, TX 76010, USA.
The University of Texas at Arlington · USRice University · USThe University of Texas Health Science Center at Houston · US
Funding
Transgenic and Mechanical Loading CoreP01AG039355 · NIA · UNIVERSITY OF MISSOURI KANSAS CITY · PI BONEWALD, LYNDA F · 2012 to 2024
$19.3M
Preserving Mitochondrial Function for Alleviating ALS ProgressionR01NS105621 · NINDS · UNIVERSITY OF TEXAS ARLINGTON · PI BROTTO, MARCO, ZHOU, JINGSONG · 2019 to 2023
$2.9M
Regulation of Store-Operated Calcium Entry During Muscle AgingR01AG056504 · NIA · OHIO STATE UNIVERSITY · PI BROTTO, MARCO, WEISLEDER, NOAH · 2018 to 2022
$2.6M
Loss of Numb in Muscle Dysfunction in AgingR01AG060341 · NIA · BRONX VETERANS MEDICAL RESEARCH FDN · PI BROTTO, MARCO, CARDOZO, CHRISTOPHER P · 2018 to 2022
$2.4M
Protecting the Diabetic Skeletal Muscle by Nampt ActivationR01DK119066 · NIDDK · UNIVERSITY OF SOUTH FLORIDA · PI BROTTO, MARCO, TIPPARAJU, SRINIVAS M. · 2019 to 2023
$2.0M
Semiconductor Biomaterials to Speed Bone Healing: A Bioengineering-Driven ApproachR01DE031872 · NIDCR · UNIVERSITY OF TEXAS ARLINGTON · PI Venu Gopal Varanasi · 2023 to 2026
$1.8M
Printing and Regenerating Fractured Bone Using Antioxidant MaterialsR56DE027964 · NIDCR · UNIVERSITY OF TEXAS ARLINGTON · PI VARANASI, VENU GOPAL · 2019 to 2019
Healing in compromised and complicated bone defects is often prolonged and delayed due to the lack of bioactivity of the fixation device, secondary infections, and associated oxidative stress. Here, we propose amorphous silicon oxynitride (SiON
Indexed as
antioxidant activityosteogenic differentiationplasma-enhanced chemical vapor depositionreactive oxygen speciessilicon oxynitride
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.